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ABSTRACT 
Supercharged Models of Intrinsically Disordered Proteins and Their Utility in Sensing 
by 
Peter J. Schnatz 
 
 
Advisor: Ronald L. Koder 
 
  
In this thesis I show that greatly increasing the magnitude of a protein’s net charge using surface 
supercharging transforms that protein into a ligand-gated or counterion-gated conformational 
molecular switch. To demonstrate this I first modified the designed helical bundle hemoprotein 
H4 using simple molecular modeling, creating a highly charged protein which both unfolds 
reversibly at low ionic strength and undergoes the ligand-induced folding transition commonly 
observed in signal transduction by intrinsically disordered proteins in biology. Due to the high 
surface charge density, ligand binding to this protein is allosterically activated by low 
concentrations of divalent cations and the polyamine spermine. To demonstrate this process 
further using a natural protein, I similarly modified E. coli cytochrome b562 and the resulting 
protein behaves in a like manner. These simple model systems allow us to derive and then 
experimentally validate a mass-action model for coupled folding and binding behavior of ligand-
gated conformational switches, establishing a set of general engineering principles which can be 
used to convert natural and designed proteins into allosteric molecular switches useful in 
biodesign, synthetic biology, and sensing.  
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Chapter 1: Introduction 
 
In the last ten years, the structural biology and biophysics communities have focused 
much effort on the role of intrinsically disordered proteins (IDPs) in biology. These proteins and 
protein domains undergo a phase transition between a disordered state and a folded state as part 
of their function 
1–5
. IDPs are found in almost every functional signal transduction pathway in 
biology, including cell cycling 
6–8
, circadian rhythms 
9,10





. While the majority of IDPs make this phase change in response to 
kinase or phosphatase action 
16–18
, a subclass of these proteins are unstructured until they bind to 
another protein or small molecule ligand – a process termed ligand-induced folding 
19–21
.  In 
some systems a layer of complexity has been added in which a protein’s interaction with another 
molecule will optimize, accelerate, or hinder a process once it has been activated; this process is 
known as allostery 
22–25
. An IDP exhibiting allosteric characteristics is not merely an on/off 
switch for its dedicated function, but now possesses the ability to control the velocity at which 
some function occurs and with what efficacy. The universality of IDPs in the proteome points to 
the utility of phase change in regulation:  as form equals function in much of molecular biology, 
having the ability to turn form itself, and thus function, on and off is a simple and attractive 
method to control individual nodes in complex interaction networks. Therefore, the ability to 
design allosteric IDPs, both by modifying natural proteins and by fully de novo IDP design, is 
critical to the success of future complex network creation efforts in synthetic biology. 
The hallmarks of IDP structure are a high net charge per residue 
26–29
, a relatively low 
core protein folding energy 
30,31
, and low sequence complexity 
32–34
. Since charged acidic and 
basic residues are common on the solvent accessible surface of the folded protein, their mutation 
 2 
often does not significantly change the fold of the final structure, yet it does effect the stability 
due to electrostatic interactions 
35–38
. The tolerance of the protein fold to these changes makes the 
net charge per residue the ideal IDP characteristic to use for modulating stability of a natively 
structured protein. Commonly, the net charge is a result of a very high charge ratio – for 
example, if the protein is negatively charged, there will be very few if any positively charged 
side chains 
39
. This partially destabilizes the folded state of the protein by charge-charge 
repulsion 
40
 and the additional folding energy that results from ligand binding is sufficient to 
drive the phase transition from an extended unliganded state to a folded bound state. 
The goal of this dissertation is to create natural and artificial IDPs that undergo a 
significant phase transition from a predominantly rigid coil to an ordered, folded structure upon 
ligand-binding using emergent computational techniques
 41–43
. I impart this behavior by 
incorporating high net charge - mutating the solvent exposed side chains of low net charge 
proteins to basic residues. The electrostatic repulsion of the negative charges destabilizes the 
structure and forces it to take on characteristics similar to a random coil conformation. By 
increasing the solution ionic strength it is possible to screen the side chain charges and reduce the 
repulsive forces, switching the energetically favorable conformation from random coil to 
natively folded. Similarly, the addition of a ligand will induce folding at the correct ionic 
strengths, exhibiting the desired IDP behavior. 
Chapter 2 of this dissertation describes the development of design principles used to 
impart IDP behavior to a natively folded de novo diheme binding tetrahelical bundle. I will 
demonstrate the use of surface residue supercharging to design a protein with a tunable dynamic 
range and phase behavior. I will also show that the modification of a protein’s surface to greatly 
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increase the magnitude of its net charge imparts the ligand-induced folding behavior found in 
natural IDPs. 
Chapter 3 describes how the principles developed in Chapter 2 can be used to impart IDP 
behavior to a natural natively folded protein, namely E. coli cytochrome b562. An iterative 
procedure will be outlined that describes controlled modulation of the stability of a supercharged 
protein by rationally selecting point mutations. Further, it will be shown that a supercharged 
extant protein can maintain its functional ability even when partially folded. 
Chapter 4 of this dissertation demonstrates that clusters of negative charge on a designed 
IDP surface imparts a high structural sensitivity to polyvalent cations, driving it to fold at ionic 
strengths over three orders of magnitude lower than for monovalent cations. Additionally, I show 
that the high density of acidic surface residues imparts cooperative ligand binding behavior in 
response to divalent cation and polyamino compound effector molecules – specific ion 
interactions that are not commonly observed in high net charge natural IDPs. 
Finally, Chapter 5 will describe future applications of this work, specifically pertaining to 
the field of biosensing. By using label-free surface plasmon resonance (SPR) spectroscopy, the 
interaction between an immobilized protein on a gold nanoparticle with its target ligand can be 
evaluated by sensing changes in the refractive index of the immediate vicinity surrounding that 
nanoparticle. I will describe how IDPs can be used to increase the sensitivity of SPR biosensing 
assays by utilizing the ligand-induced folding properties, which will have an enhanced effect on 
the refractive index change surrounding the gold nanoparticles. I will also present preliminary 
results showing the potential for the magnitude of this effect compared to the usual assay which 
uses proteins that are natively folded. 
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This work thus presents a roadmap for the refashioning of natural and designed globular 
proteins into cooperative IDPs which may prove useful in the design of new control mechanisms 
in natural and designed metabolic networks and in the development of improved biosensors, as 
well as creating a new class of maquettes for the study of natural IDP function. 
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Chapter 2: Imparting Intrinsic Disorder to a de novo Protein 
 
2.1 Sequence Specific Characteristics of IDPs 
Since their discovery less than 30 years ago, the library of proteins empirically known to 
be fully or partially unstructured has grown rapidly. The Disordered Protein Database, DisProt 
44
, 
currently contains over 800 entries with experimental evidence for disorder collected from 
literature. And the Protein Order and Disorder Database, PODD 
45
, which contains statistical 
ensembles of conformationally heterogeneous states, has over 5000 entries. Furthermore, full 
proteome studies using computational disorder predictors 
46–48
 have shown the disorder content 
of eukaryotic and bacteria proteomes average 20.5% and 8.5%, respectively 
49
. The human 
proteome contains an abundance of IDPs with over 30% disorder 
50
.  
The incontrovertible ubiquity of IDPs has led to investigations into the amino acid 
composition of proteins and protein domains that are natively unstructured. Early studies of the 
amino acid composition have shown that a large net charge and weak hydrophobic character can 
impart structural instability leading to a natively unstructured protein 
27,28,51,52
. The interplay 
between these sequence specific characteristics will determine if a structure is natively unfolded. 
Using a normalized version of the Kyte and Doolittle approximation of amino acid 
hydrophobicity 
53
, the mean hydrophobicity per residue, 〈𝐻〉, can be calculated. Accordingly, for 
a protein domain to be intrinsically disordered, 〈𝐻〉 and the absolute mean net charge per residue 
〈𝑅〉 must satisfy the following constraint 29: 
 〈𝑅〉 > 2.785〈𝐻〉 − 1.151. (1) 
However, net charge per residue is an inadequate predictor for identifying IDPs because a 
protein may still be unstructured if the total fraction of charged residues is high and the number 
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of oppositely charged residues is relatively the same. Also, if the linear distribution of charged 
residues within a near-neutral protein shows clustering of like-charges within domains and 
regions, then IDP behavior can be still expected 
39
. Pappu and coworkers have compiled 
experimental data
29,54–57
 on IDPs to develop a map predicting the phase structure, i.e. random-
coil, molten globule, or native, based on the fraction of charged residues 
39,40
. 
 I have implemented these sequence specific constraints throughout this work in designing 
functional IDPs and imparting IDP behavior to natively folded designed and extant proteins. 
 
2.2 Materials and Methods 
2.2.1 Cloning, Expression, and Purification. The N4(-28) gene was synthesized 
(GeneWiz) with an N-terminal TEV protease cut site and inserted between the BglII and XhoI 
restriction sites of the pET32a(+) vector plasmid (Novagen). Plasmid DNA was chemically 
transformed into BL21(DE3) E. coli cells for expression. The protein was expressed as a fusion 
with thioredoxin and purified via hexa-histidine-tag (his-tag) purification procedures: a 2 L 
culture of BL21(DE3) E. coli containing the plasmid carrying the N4(-28) gene was grown at 37° 
C and induced to express with the addition of 1 mM isopropyl-ß-D-thiogalactoside when OD600 
reached approximately 1.2. The culture was shaken overnight for up to 16 h at 18° C or for 2.5 h 
at 37° C. Cells were harvested by centrifugation then lysed via high-pressure cell disruption 
using a French press. Lysate cell debris was separated by centrifugation and the target fusion 
protein was purified via a Ni-nitrilotriacetic acid (Ni-NTA) chromatography (Qiagen) according 
to the manufacturer’s instructions. The collected fusion protein was dialyzed into 4 L of 50 mM 
Tris-HCl, 1 M NaCl, pH 8.0. The reducing agent, dithiothreitol (DTT), was added to a final 
concentration of 1 mM and tobacco etch virus protease was added to cleave N4(-28) from the 
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his-tag and thioredoxin overnight at room temperature. The N4(-28) was purified from the his-
tagged thioredoxin via another round of Ni-NTA chromatography and then dialyzed into 6L of 
20 mM ammonium carbonate, 2 mM dextrose, pH 7.5 and lyophilized. Finally, resuspended 
protein was purified with a C18 reverse-phase column (Western Analytical) using high 
performance liquid chromatography (Shimadzu) and lyophilized to a pure product. Protein 
identity was confirmed by mass spectrometry with a Bruker Autoflex Speed TOF-TOF. 
15
N-Labeled Protein — 
15
N isotopically labeled protein were grown in M9 minimal media 
containing 
15
NH4Cl as the only nitrogen source 
58
. All subsequent growth and purification 
procedures are the same as for unlabeled protein. 
2.2.2 Salt Refolding. CD spectra were recorded on an Aviv Biomedical Circular 
Dichroism Spectrometer Model 400 in a quartz cell with a 0.2 cm light path, using a bandwidth 
of 1 – 2 nm, an averaging time of 2 s, and averaged over two scans. 
 For salt refolding experiments, concentrated apo-N4(-28) stocks were prepared at 30 μM 
in 20 mM boric acid, 50 mM NaCl, pH 9.0.  The stocks were diluted to 2.5 μM in a range of salt 
concentration from 50 mM to 2000 mM NaCl. Spectra were recorded between 204 nm and 250 
nm, with background correction. The spectra were observed as ellipticity ([𝜃]𝑜𝑏𝑠 mdeg), and the 
mean residue ellipticity ([𝜃], mdeg2 cm dmol-1 residue-1) was calculated as  
 [𝜃] = [𝜃]𝑜𝑏𝑠/(10𝑙𝑐𝑁), (2) 
where 𝑙 is the light path length in centimeters, 𝑐 is the sample concentration in millimoles per 
liter, and 𝑁 is the number of amino acids in one macromolecule. Protein secondary structure 
percentages were calculated with K2D3 
59
 using data points ranging from 204 nm to 240 nm.  
To determine the folding energy of the apoprotein at varying ionic strength the ellipticity 
at 222 nm, [𝜃]222, was plotted as a function of NaCl concentration. The lowest value of [𝜃]222 
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reached for the salt titration was considered the point at which the helical bundle is 100% folded 
and assigned [𝜃]222,folded. The 0% folded baseline ([𝜃]222,unfolded) is calculated by using K2D3 
59
 to determine the predicted alpha-helix percentage (𝑓) at its fully-unfolded state and 




.  (3) 
The ensemble fraction of protein folded at each salt concentration can be calculated from 
the data using Equation 3. Finally, the folding energy as a function of ionic strength, 𝛥𝐺, can be 
calculated as 




where 𝑅 is the universal gas constant, 𝑇 is the absolute temperature, and 𝐾𝑒𝑞 is the equilibrium 
constant between folded and unfolded states. 
2.2.3 Chemical Denaturation. Apo-N4(-28) stocks were prepared at 30 μM in 20 mM 
boric acid, pH 9.0 and at four salt concentrations (750, 1000, 1500, 2000 mM NaCl). The stocks 
were diluted to 2.5 μM in a range of urea concentrations from 0 to 8 M. CD spectra showed no 
significant change when the samples were equilibrated for 24 h, therefore equilibration time was 
not strictly monitored and was normally on the order of minutes. Spectra were recorded between 
210 nm and 250 nm, with background correction. The observed ellipticity spectra were 
converted to mean residue ellipticity using Equation 2 and protein secondary structure was 
calculated with K2D3 
59
 using data points ranging from 210 nm to 240 nm. To determine the 
folding energy at each salt concentration, the urea melt curves were fit with least squares 









Here, 𝛥𝐺0 is the folding energy, 𝑚 is an empirical constant determining how the stability 
changes with denaturant concentration and is related to the change in accessible surface area of 
the protein as it transitions from folded to denatured 
61,62
, [𝐷] is the denaturant concentration, 𝑅 
is the universal gas constant, and 𝑇 is the temperature. Also, [𝜃]𝑁 = 𝜉𝑁[𝐷] + 𝜉0,𝑁 and [𝜃]𝑈 =
𝜉𝑈[𝐷] + 𝜉0,𝑈 determine how the signal of the native and unfolded states change with denaturant 
concentration, where 𝜉0,𝑖 are the y-intercepts of the native and denatured baselines and 𝜉𝑖 are the 
slopes of the baselines. 
2.2.4 Cofactor Binding. UV-Vis Spectroscopy — Optical spectra were recorded with a 
Hewlett-Packard 8452A diode array spectrophotometer. Apoprotein samples were 0.5 μM in 20 
mM boric acid, pH 9.0 with varying NaCl concentrations specifically noted throughout. 
Experiments were performed in 1 cm path length glass cuvettes. The cofactor, Fe(III) 
Isohematoporphyrin IX (IHP) (Frontier Scientific), was suspended in DMSO at concentrations 
between 1 mg/mL and 10 mg/mL. Successive 0.3 – 5 equivalent additions of IHP were followed 
by at least a 1.5 min equilibration period. Optical spectra were collected after each equilibration 
period and the cofactor binding was monitored using the bound IHP Soret peak at 404 nm. 
Values for 𝐾𝑑 were obtained from plots of the Soret band absorbance (𝐴404) measured at 404 nm 
vs. the concentration of IHP added and fit with least squares regression analysis using the tight 
binding equation: 
 
 𝐴 = 𝐴0 + 𝜖𝑢𝑛𝑏[IHP]
+ 𝜖𝑏𝑛𝑑[prot] [







where 𝐴0 is the initial absorbance at 404 nm, 𝜖𝑢𝑛𝑏 is the molar absorption coefficient of unbound 
IHP at 404 nm, 𝜖𝑢𝑛𝑏 is the additional absorbance of bound IHP at 404 nm, [IHP] is the IHP 
concentration, [prot] is the protein concentration, and Kd is the dissociation constant for oxidized 
IHP at a specified salt concentration. 
 Circular Dichroism Spectroscopy — At low NaCl concentrations, cofactor binding was 
monitored via CD spectrometry. Apoprotein samples were 2.5 μM in 20mM boric acid, pH 9.0 
and the specified NaCl concentration. Experiments were performed in a 0.2 cm path length 
quartz cuvette. IHP was prepared in 100 mM NaOH at 10 mg/mL.  Successive 0.25 – 50 
equivalent additions of IHP were followed by a 5 min equilibration period. CD spectra were 
collected after each equilibration period and the cofactor binding was monitored by the ellipticity 
at 222 nm, [𝜃]222. Values for Kd were determined from plots of the [𝜃]222 vs. the concentration 
of IHP least squares fit to Equation 6. 




H-NOESY — Apoprotein was 
concentrated using Centricon YM-3 centrifugal filter concentrators (Millipore). The sample was 
directly exchanged into D2O buffer, 20 mM borate, pH 9.0 with the desired NaCl concentration, 
using a PD-10 desalting column (GE Healthcare). Three equivalents of heme were added to the 
holo-sample prior to buffer exchange. D2O was added to all samples to 10% v/v. Samples were 
transferred to 3 mm NMR tubes and nuclear Overhauser effect spectra (NOESY) were taken 






N-labeled N4(-28) samples were prepared in the same method as for 
NOESY NMR. Samples were exchanged into 90%H2O/10%D2O v/v buffered with 20 mM 






N heteronuclear multiple quantum correlation (HSQC) spectra were taken using 
a Bruker AVANCE III HD 700 MHz NMR spectrometer. 
2.2.6 ANS Assay. Monitoring folding — A 10 µM sample of apoprotein was prepared at 
20 mM MOPS, 15 mM NaCl, pH 7.0 with a 50-fold excess of ANS. The sample was titrated 
with CaCl2 up to 150 mM and the emission spectrum of ANS was monitored via fluorescence 
spectroscopy. The excitation wavelength was 370 nm and the emission spectrum was collected 
between 400 and 600 nm. 
Monitoring heme binding — A 10 µM sample of apoprotein was prepared at 20 mM 
MOPS, 15 mM NaCl, 150 mM CaCl2. The sample was titrated with heme up to 33 µM and the 
emission spectrum of ANS was monitored via fluorescence spectroscopy. The excitation 
wavelength was 370 nm and the emission spectrum was collected between 400 and 600 nm. 
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2.3 Redesigning H4 with IDP Sequence Constraints 
The starting point is the designed single-chain diheme tetrahelical bundle protein H4(-
16), which is a single-chain variant of the homodimeric protein HP-7 
41,63
. Apo-H4 has a surplus 
of negatively charged residues – 16 more acidic than basic residues (Figure 1A). Because of this,  
 
Figure 1: Alphas-carbon representation of H4(-16) (A) and N4(-28) (B). The corresponding amino acid sequence is shown below 
each structure with alpha-helix forming regions underlined. The solvent exposed acidic and basic residues are colored red and 
blue, respectively. The heme porphyrins are shown in their binding sites as orange stick models. 
 
the apoprotein partially unfolds at low ionic strength as evidenced by a distinctive band at 222 
nm when measured by circular dichroism spectroscopy (Figure 2). At low ionic strength, 50 mM 
NaCl, H4(-16) is 35% helical as estimated using the circular dichroism protein secondary 
structure predictor website K2D3 
59
. I set out to amplify the property of unfolding at low ionic 
strength by increasing the net charge. The software package ProtCAD 
64
 was used to create a 
structural model for holo-H4, and every fully surface-exposed side chain was charged to 
glutamic acid, creating an H4 variant termed N4(-52) with 52 excess negatively charged side 
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chains. H4 also contains low helical-propensity aspartate and asparagine side chains 
65
 that were 
added to increase chemical shift dispersion 
63
, and these were reverted to their high-propensity 
analogues glutamate and glutamine. This protein did not fully fold even at high salt 
concentrations. 52 acidic residues comprise 40% of the residues, a net charge per residue higher 
than the 35% cut-off value identified by Pappu and coworkers as the random coil limit 
39
. I then 
created the protein N4(-28) by changing every lysine residue in H4 to glutamine and hand-
selecting a subset of surface-exposed residues to become acidic such that 21% of the protein side 
chains are negatively charged, there are no basic residues except for the four heme ligand 
histidines, and the charged surface side chains are maximally distant from each other. This net 




Figure 2: A. Ellipticity spectra of H4(-16) as measured by circular dichroism spectroscopy at increasing NaCl concentrations. B. 
The ellipticity value at 222 nm, corresponding to the absorption band indicative of alpha-helical structure plotted as a function of 




2.4 Salt Dependence of the Folding Energy 
In pH 9.0, 20 mM borate buffer, apo-N4(-28) has a circular dichroism (CD) spectrum 
indicative of a predominantly random coil structure at NaCl concentrations less than 200mM 
(Figure 3A). Helices form as the salt concentration is increased, and the CD spectra show the 222 
nm band characteristic of alpha-helices (Figure 3A). The protein becomes predominantly helical 
at concentrations over 1 M NaCl (Figure 3B). Figure 4 illustrates the salt-induced folding 
transition of N4(-28) as detected by circular dichroism: at low salt concentrations the protein 
takes on a random coil conformation, which folds to the native-like tetrahelical bundle as the 
ionic strength increases. 
 
Figure 3: A. Ellipticity spectra of apo-N4(-16) as measured by circular dichroism spectroscopy at increasing NaCl 
concentrations. B. The ellipticity value at 222 nm, corresponding to the absorption band indicative of alpha-helical structure 
plotted as a function of NaCl concentration. Protein was prepared at a concentration of 2.5 µM in 20 mM borate, pH 9.0 and 




Figure 4: A schematic illustration of the N4(-28) phase transition from an extended random coil to a folded tetrahelical bundle 
upon the addition of NaCl. 
 
Figure 5 depicts urea denaturation experiments conducted at higher salt concentrations, 
between 750 and 2000 mM.  The folding energies, 𝛥𝐺fold, from the fits to Equation 5 are 
summarized in Table 1. Similar to the salt plot of Figure 3B, the results show that increased ionic 
strength stabilizes the folded state of apo-N4(-28). 
 
 
Figure 5: Urea melts of N4(-28) at pH 9.0, 20 mM borate with NaCl concentrations ranging from 0.75 to 2 M. The fits were 
calculated using the non-linear method of least squares to Equation 5. The melt for each salt concentration was performed three 
times and averaged. The error bars show the standard deviation of three trials at each salt concentration. 
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[NaCl] (M) 𝛥𝐺fold (kcal/mol) 
0.75 -0.7 ± 0.1 
1.00 -2.4 ± 0.5 
1.50 -4.7 ± 0.2 
2.00 -6.5 ± 0.2 
Table 1: The folding energy of N4(-28) at salt concentrations ranging from 0.75 to 2 M as determined by urea melt and least 
squares fit to Equation 5. Errors are determined using the inverse matrix method. 
 
Together, the salt titration and urea melt data demonstrate that the folding energy of apo-
N4(-28) depends linearly on salt concentration over a range of 8 kcal/mole (Figure 6). At ionic 
strength less than approximately 400 mM NaCl, the electrostatic repulsion of the neighboring 
negatively charged glutamate residues cannot be overcome by the hydrophobic effect, thus 
driving the ensemble to be in an extended state. At ionic strength greater than 400 mM NaCl, the 
electrostatic fields of the charged residues begin to be screened by the ions in solution. This 
screening effect reduces the electrostatic energy of the structure, allowing the hydrophobic effect 





Figure 6: Stability of apo-N4(-28) at 20 mM borate, pH 9.0 as a function of NaCl concentration as measured by salt titration and 
urea melt. The data was fit with a linear best fit line. 
 
Although CD spectra indicate that the ensemble of N4(-28) is more than 90% folded at 
salt concentrations greater than 1 M NaCl (Figure 3B), the free energy of folding continues to 
decrease at a constant rate well beyond this threshold (Figure 6). This continuous decrease of the 
folding energy far into the regime where the entire ensemble is folded indicates that screening 
effects influence the stability of the folded structure with equal magnitude as when the structure 
energetically favors the unfolded state. The invariable slope of Figure 6 suggests that only the 
solvent exposed residues are influenced by ionic strength and the core residues, which are 









N-HSQC spectra of the apoprotein at low salt, 50 mM NaCl, are 
consistent with an extended conformation 
66–68
 (Figure 7A and Figure 8A). Due to the high 
flexibility of N4(-28) at low ionic strength, the chemical shift contributions are averaged out and 
many resonances overlap.  At high salt, 1000 mM for NOESY and 750 mM for HSQC, 
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apoprotein has NMR spectra consistent with that of a molten globule, the same structural state 
that the apoprotein form of H4’s progenitor protein, HP7, forms (Figure 7B and Figure 8B) 
63
. 
The molten globular state will allow some freedom for the helices to move relative to each other, 
disallowing full dispersion of resonance peaks due to discrete chemical shifts. This data 
demonstrates that Figure 4, illustrating the phase change of N4(-28) with increased ionic strength 
would be better represented as transitioning from extended coil to molten globular, not native 
(Figure 9). 
 
Figure 7: 1H-1H NOESY NMR of apo-N4(-28) in 20 mM borate, pH 9.0 with 50 mM NaCl (A) and 1000 mM NaCl (B). 
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Figure 8: 1H-15N HSQC NMR of apo-N4(-28) in 20 mM NaH2PO4, pH 7.0 with 50 mM NaCl (A) and 750 mM NaCl (B). 
 
Figure 9: A schematic illustration of the N4(-28) phase transition from an extended random coil to a folded tetrahelical bundle 
upon the addition of NaCl. 
This data demonstrates that the folding energy of apo-N4(-28) depends linearly on salt 
concentration as the electrostatic screening increases; however, it does not reach its lowest 
energy native conformation by charge screening alone. Importantly, at low salt concentrations 
the folding energy is positive, offering the opportunity for folding to be triggered by the coupled 
stabilizing energy of cofactor binding.
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2.5 Ligand-Induced Folding 
Thermodynamic measurements of heme binding were not successful at high salt 
concentrations because ferric and ferrous hemes both form irreversible aggregates on a minutes 
time scale (not shown).  Instead the heme analogue Fe(III)-isohematoporphyrin IX (IHP) (Figure 
10) was used, which was found to be soluble for hours at NaCl concentrations up to 1 M.  The 
tetrahelical bundle N4(-28) binds two equivalents of IHP in a hexacoordinate manner and is bis-
histidine-ligated in the oxidized state (Figure 11). At 20 mM borate, 1 M NaCl, pH 9.0, when the 
protein is in its molten globular state according to NMR spectroscopy, N4(-28) binds tightly to 
two molecules of IHP independently (Figure 11), with a dissociation constant of 0.21 ± 0.02 µM. 
As the ionic strength of the solution is lowered, the dissociation constant increases, indicating 
that IHP binds less tightly with decreased NaCl concentration. At 300 mM NaCl, the binding 
constant is too weak to monitor via the Soret band using UV-Vis spectroscopy. As an alternative, 
CD spectroscopy was used and the ellipticity at 222 nm was monitored to determine the binding 
constant: 25 ± 5 µM (Figure 12). No cooperativity was detected at any salt concentration. 
Table 2 and Figure 13 summarize the dissociation constants, 𝐾𝑑, and the corresponding 
apparent binding energies, 𝛥𝐺bind
app
, of N4(-28) in the range 300 mM — 1000 mM NaCl, for 
which there is over a 100-fold increase of the dissociation constant of IHP. 
 
Figure 10: Structure of Fe(III)-isohematoporphyrin IX; a bis-His binding porphyrin with higher water solubility than heme. 
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Figure 11: A. Absorption spectra of N4(-28) titrated with concentrated IHP in 20 mM borate, 1000 mM NaCl, pH 9.0. B. Replot 
of the IHP Soret band at 404 nm during titration. Data is fit to Equation 6. 
 
Figure 12: A. Ellipticity spectra of N4(-28) as measured by circular dichroism spectroscopy at increasing IHP concentrations at 
20 mM borate, 300 mM NaCl, pH 9.0. B. Replot of the ellipticity value at 222 nm, corresponding to the absorption band 
indicative of alpha-helical structure plotted as a function of IHP concentration. Protein was prepared at a concentration of 2.5 µM 
in 20 mM borate, 300 mM NaCl, pH 9.0. Data was fit to Equation 6. 
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3  
Figure 13: The dissociation constant of N4(-28) binding with two IHP molecules as a function of salt concentration buffered 
with 20 mM borate, pH 9.0. The binding constant was determined using the method of least squares fit to Equation 6 and 
averaged over 3-4 trials. The error bars are the standard deviation of the data at each salt concentration. 
[NaCl] (M) 𝐾𝑑 (µM) 𝛥𝐺bind
app
 (kcal/mol) 
0.30      25 ± 5         -6.3 ± 0.1 
0.40        7 ± 1       -7.12 ± 0.08 
0.50     2.2 ± 0.1       -7.82 ± 0.03 
0.60   2.16 ± 0.05       -7.82 ± 0.01 
0.75     0.5 ± 0.2         -8.7 ± 0.3 
1.00     0.2 ± 0.02       -9.24 ± 0.07 
 
Table 2: The dissociation constant, 𝑲𝒅, and apparent binding energy, 𝜟𝑮𝐛𝐢𝐧𝐝
𝐚𝐩𝐩
, of N4(-28) with IHP over a range of salt 
concentrations. Dissociation constants are determined using least squares fits of binding curves to Equation 6 and errors are 
determined using the inverse matrix method. 
 
Notably, a measurable binding constant is obtained at 300 mM NaCl, a salt concentration 
where N4(-28) is predominantly unfolded. Circular dichroism spectra of the protein during the 





NOESY analysis of the holoprotein under the same conditions demonstrates the degree of 





N-HSQC performed at 20 mM NaH2PO4, 100 mM NaCl, pH 7.0, also showed a 
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great increase in chemical shift dispersion of the holoprotein vs both the extended and molten 
globular apoprotein. The HSQC resolution increase upon binding IHP is especially significant, 
since a salt titration at pH 7 indicates that N4(-28) is merely 11% folded.  Thus under both of 
these solution conditions, i.e. 20 mM borate, 300 mM NaCl, pH 9.0; and 20 mM NaH2PO4, 100 
mM NaCl, pH 7.0, N4(-28) exhibits the ligand-induced folding behavior, going from an 
extended random coil structure to a native-like folded structure, seen in natural IDPs. 
 
 
Figure 14: A. 
1H-1H-NOESY NMR of holo-N4(-28) in 20 mM borate, 300 mM NaCl, pH9.0. B. 1H-15N-HSQC NMR of holo-
N4(-28) in 20 mM NaH2PO4, 100 mM NaCl, pH 7.0. 
 
To corroborate the NMR data, an ANS assay was performed. The fluorescent dye 8-
anilino-1-naphthalenesulfonic acid (ANS) has been commonly used as probe for clusters of 
hydrophobic residues in proteins 
69–71
. At low ionic strength, when N4(-28) is an extended coil, 
the ANS has a characteristic unbound fluorescence peak at 525 nm (Figure 15A). When the ionic 
strength is increased, the peak increases in magnitude and blue shifts, indicating that the ANS 
has bound to a the hydrophobic environment created in the core of the molten globule N4(-28). 
Furthermore, when the heme ligand is introduced, the magnitude of the ANS fluorescence 
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decreases and red shifts (Figure 15B). When the heme binds, the protein fold is locked into 
place, tightening the core and displacing the ANS. 
 
Figure 15: A. ANS emission spectrum with unfolded apo-N4(-28) at 20 mM MOPS, 15 mM NaCl and bound to molten globule 
N4(-28) after the addition of 100 mM CaCl2. B. ANS emission spectrum bound to folded N4(-28) at 20 mM MOPS, 15 mM 
NaCl, 100 mM CaCl2, and unbound after the heme is introduced to bind to the protein core. 
 
This data leads to the coupled folding and binding scheme in Figure 16, where N4(-28) 
can take the path of transitioning from extended random coil to molten globule with increased 
ionic strength, then locking into a native-like folded structure upon binding to IHP. However, the 
ligand-induced folding pathway, typical of natural IDPs, is also available at experimentally 
determined NaCl concentrations. 
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Figure 16: Thermodynamic box of N4(-28) indicating three possible states: extended random coil, molten globule, and native-
like bound. The red arrow demonstrates the pathway of ligand-induced folding typical of many natural IDPs. The energy change 
for each leg of the cycle is related to its measurable equilibrium constant. 
  
2.5.1 Coupled Binding and Folding.  The apparent binding energy of the ligand under a 
particular solution condition is the intrinsic interaction energy between the ligand and the folded 
protein (ΔGbind) increased by the energetic cost required to shift the protein population 





=  ΔGbind + ΔGfold. (7) 
This ligand-induced folding is illustrated in Figure 16 where ΔGfold and Kfold are the apoprotein 
folding energy and equilibrium constant, ΔGbind and Kd are the binding energy and intrinsic 




 are the 
binding-folding energy and dissociation constant measured for a two-state equilibrium 








which demonstrates that the apparent binding energy is a function of the folding energy of the 
unbound protein. The intrinsic dissociation constant, Kd, is a fixed parameter for the cofactor-
binding site pair. In N4(-28), IDP behavior is imparted by the addition of negatively charged 
residues to the surface of the folded structure, making ΔGfold a tunable parameter sensitive to the 
ionic strength of the environment.  
As Equation 8 predicts and Figure 13 demonstrates, increasing salt concentrations 
exponentially decreases the apparent dissociation constant up to the 1M salt limit by decreasing 
the energetic cost of folding, and the apparent binding energy decreases linearly with Debye 
length, which describes the distance that the electrostatic effect of a charge persists in an 
electrolyte solution (Figure 17).   Interestingly, binding becomes tighter even after the protein is 
predominantly folded as detected by circular dichroism. 
 
 
Figure 17: The apparent binding energy of N4(-28) with IHP at 20 mM borate, pH 9.0 as a function of Debye length. 
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 When plotted together (Figure 18A), it is obvious that the values of the apparent binding 
energy, ΔGbind
app
 and the folding energy, ΔGfold, as a function of salt concentration are 
approximately parallel. From the closed thermodynamic box of Scheme 1, the intrinsic binding 
energy is equal to the apparent binding energy when the folding energy is zero, i.e. when there is 
an equal population of unfolded and folded states; this occurs at a salt concentration of 400 ± 10 
mM. The apparent binding energy at this salt concentration is -7.11 ± 0.08 kcal/mol, 
corresponding to an apparent dissociation constant of 7 ± 1 µM. The average distance between 
the two lines is -7.1 ± 0.4 kcal/mol, indicating that the model in Figure 16 holds over the range of 
salt concentrations that are experimentally accessible, and the interaction energy between IHP 
and the folded protein is the separation. When plotted as a function of Debye length, the folding 
energy of N4(-28) shows two distinct regions where the energy drops faster at lower Debye 
lengths. The change in slope occurs at approximately 3.5 Å, which may be about twice the 
closest distance that the carboxyl groups of neighboring glutamate residues can achieve when not 
hindered by electrostatic forces. This demonstrates that the most difficult electrostatic force to 
overcome, namely that between neighboring glutamate residues, is effectively turned off once 




Figure 18: The folding energy of N4(-28) and the binding energy of IHP to N4(-28) plotted together as a function of A. NaCl 
concentration and B. Debye length at 20 mM borate, pH 9.0. 
 
 Thus I have shown that for a supercharged protein, the effective binding constant can be 
controlled using the salt concentration with a dynamic range of at least 142.9 ± 0.2 fold, 
suggesting that for a given salt concentration the effective binding constant could likewise be 
controlled over a similar range by adjusting the surface charge density.
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Chapter 3: Imparting IDP Behavior to a Natural Protein 
 
3.1 Supercharging E. coli cytochrome b562 
To demonstrate that the design principles I have developed in Chapter 2 can be used to 
impart IDP behavior to other proteins, I have selected the four alpha-helix bundle E. coli 
cytochrome b562 for supercharging. This soluble, 106 residue protein non-covalently binds a 
single b-type heme. Both the apo- 
73
 and holoprotein 
74
 structures have been solved, providing a 
unique and well-established landscape for developing an intrinsically disordered version capable 
of ligand-induced folding. Wildtype cytochrome b562 has a net charge of -3, and the holoprotein 
has been shown to have slightly more helical content than the apoprotein 
75
. To allow for easy 
tracking and concentration determination, an absorptive tryptophan residue has been substituted 
into the structure (F61W); this mutation has proven to be tolerable with only small changes to the 
apoprotein folding energy and heme binding constant 
76
. I have denoted the wildtype cytochrome 
b562 with the F61W mutation b562(WT) (Figure 19). 
A supercharged cytochrome b562, has been designed using a combination of 
computational techniques 
77
 and simple modeling to select solvent-exposed basic and 
neutral residues as candidates for mutation to neutral and acidic amino acids. I focused the 
mutations on arginine, lysine, asparagine, and glutamine, with few exceptions, and I did not 
mutate residues essential for heme binding or in close proximity to the binding site. My initial 
design has 19 mutations to generate a net charge of -27, denoting the new protein b562(-27), 
constituting a charge per residue of approximately -0.25 (Figure 19). Having 27 more acidic 
residues than basic ones placed the net charge at 25% of the total protein, an amount that is 
below the 35% cut-off identified by Pappu as the random coil limit 
39
; however, it is slightly 
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higher than the 21% characteristic of N4(-28). Since mutating residues near the heme binding 
site was avoided, there remains five positively charged residues in the protein. The combination 
of positively and negatively charged residues will have a stabilizing affect on the protein 
78,79
, 
which was the motivation to increase the net charge percentage from 21%, like that of N4(-28), 
to 25%. All charged residues are maximally distant from each other in order to distribute charge, 
and consequently instability, over the entire structure. 
 
Figure 19: Alphas-carbon representation of b562(WT) (A) and b562(-27) (B). The corresponding amino acid sequence is shown 
below each structure with alpha-helix forming regions underlined. The solvent exposed acidic and basic residues are colored red 
and blue, respectively. The heme porphyrins are shown in their binding sites as orange stick models. 
 
 
3.2 Materials and Methods 
3.2.1 Cloning, Expression, Purification, and Point Mutations. The proteins, b562(WT) 
and b562(-27) genes was synthesized (GeneWiz) with an N-terminal TEV protease cut site and 
inserted between the BglII and XhoI restriction sites of the pET32a(+) vector plasmid 
(Novagen). Point mutations were made using the Q5® Site-Directed Mutagenesis Kit (New 
England BioLabs) according to the manufacturer’s instructions. Expression and purification of 
b562(WT), b562(-27), and the subsequent generations with point mutations is described in detail 
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in section 2.3.1. Primers for point mutations and full sequences of all b562 variants are in Table 
3 and Table 4. 
3.2.2 Salt Refolding. CD spectra were recorded on an Aviv Biomedical Circular 
Dichroism Spectrometer Model 400 in a quartz cell with a 0.2 cm light path, using a bandwidth 
of 1 – 2 nm, an averaging time of 2 s, and averaged over two scans. 
 For salt refolding experiments, concentrated apoprotein stocks were prepared at 30 μM in 
20 mM MES, 15 mM NaCl, pH 5.5 or 20 mM MOPS, 15 mM NaCl, pH 7.0.  The stocks were 
diluted to 2.5 μM in a range of salt concentration from 0.8 mM to 3940 mM NaCl. Spectra were 
recorded between 210 nm and 250 nm, with background correction. Analysis of the spectra and 
determination of the folding energy is described in section 2.3.2. 
3.2.3 Cofactor Binding. Binding Constant Determination — Optical spectra were 
recorded with a Hewlett-Packard 8452A diode array spectrophotometer. Apoprotein samples 
were 1 μM in 20 mM MES, pH 5.5 with varying NaCl concentrations specifically noted 
throughout. Experiments were performed in 1 cm path length glass cuvettes. The cofactor, 
Fe(III) Isohematoporphyrin IX (IHP) (Frontier Scientific), was suspended in DMSO at 
concentrations between 1 mg/mL and 10 mg/mL. Successive 0.3 – 5 equivalent additions of IHP 
were followed by at least a 5 min equilibration period. Optical spectra were collected after each 
equilibration period and the cofactor binding was monitored using the bound IHP Soret peak at 
406 nm. Values for Kd were obtained from plots of the Soret band absorbance (𝐴406) measured 
at 406 nm vs. the concentration of IHP added and fit with least squares regression analysis using 
Equation 6. 
Kinetics — Optical spectra were recorded with a Hewlett-Packard 8452A diode array 
spectrophotometer. Apoprotein samples were 5 μM in 20 mM MOPS, pH 7.0 with varying NaCl 
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concentrations specifically noted throughout. Experiments were performed in 1 cm path length 
glass cuvettes. The cofactor, Fe(III) Isohematoporphyrin IX (IHP) (Frontier Scientific), was 
suspended in DMSO at concentrations between 1 mg/mL. One addition of 1 equivalents of IHP 
was added and quickly mixed. Spectra were collected every 30.44 s for up to 30 min. Rate 
constants for IHP binding were determined by replotting the Soret band absorbance, 𝐴406, 
against time and fitting to the equation 
 𝐴406 = 𝐴0𝑒
−𝑘𝑡 + 𝑏. (9) 








Table 3: Protein sequences for E. coli cytochrome b562 variants. 
Protein Protein Sequence 
b562(WT) 
GADLEDNMET LNDNLKVIEK ADNAAQVKDA LTKMRAAALD AQKATPPKLE DKSPDSPEMK 
DFRHGFDILV GQIDDALKLA NEGKVKEAQA AAEQLKTTRN AYHQKYR  
b562(-27) 
GADLEDNMET LNDNLQVIEK ADNAAQVEDA LEQMEAAALD AQQATPPKLE DQSPDSPEMS 
DWEEGFDILV EEIDDALELA NEGQVEEAQA AAEELKETRN AYHQEYR 
b562(-25) 
GADLEDNMET LNDNLQVIEK ADNAAQVEDA LTQMEAAALD AQQATPPKLE DQSPDSPEMS 
DWEEGFDILV EEIDDALELA NEGQVEEAQA AAEELKTTRN AYHQEYR  
b562(-21) 
GADLEDNMET LNDNLQVIEK ADNAAQVEDA LTQMEAAALD AQQATPPKLE DQSPDSPEMS 
DWEHGFDILV GEIDDALKLA NEGQVEEAQA AAEELKTTRN AYHQEYR 
b562(-19) 
GADLEDNMET LNDNLKVIEK ADNAAQVEDA LTQMEAAALD AQQATPPKLE DQSPDSPEMS 
DWEHGFDILV AEIDDALKLA NEGQVEEAQA AAEQLKTTRN AYHQEYR 
b562(-18) 
GADLEDNMET LNDNLKVIEK ADNAAQVEDA LTQMEAAALD AQQATPPKLE DQSPDSPEMK 







Table 4: Primers for variants of E. coli cytochrome b562. 
Primer Name Primer Sequence Predecessor Protein 
b562-F61W_F TGGCGTCACGGTTTCGACATTCTGGTTG Wildtype cytochrome b562 
b562-F62W_R GTCTTTCATTTCTGGGGAGTCTGGAGATTTGTCC b562(-27) 
SC-b562-E31T_F ACGCAAATGGAGGCTGCCGCACTGG b562(-27) 
SC-b562-E31T_R TAAAGCGTCTTCAACTTGGGCTGCATTATCTGCTTTCTCG b562(-27) 
SC-b562-E96T_F ACCACCCGTAACGCCTACCACCAAG b562(-27) 
SC-b562-E96T_R TTTCAGCTCTTCGGCAGCAGCTTGGGC b562(-27) 
SC-b562-E70G_F GGCGAGATTGATGATGCTTTAGAGCTGGCGAACGAAGG b562(-25) 
SC-b562-E70G_R CACCAGAATGTCGAAGCCTTCCTCC b562(-25) 
SC-b562-E63H_F CATGGCTTCGACATTCTGGTTGGTGAGATTGATGATGC b562(-25) 
SC-b562_E63H_R CTCCCAATCGCTCATTTCAGGGCTATCTGGG b562(-25) 
SC-b562-E77K_F AAGCTGGCGAACGAAGGTCAAG b562(-25) 
SC-b562-E77K_R TAAAGCATCATCAATCTCTCCCACCAGAATGTCGAAGC b562(-25) 
SC-b562-Q15K_F AAGGTTATCGAGAAAGCAGATAATGCAGCCCAAG b562(-21) 
SC-b562-Q15K_R TAAATTGTCGTTTAAAGTCTCCATGTTATCCTCCAGATCG b562(-21) 
SC-b562-E93Q_F CAACTGAAAACCACCCGTAACGCCTACC b562(-21) 
SC-b562-E93Q_R TTCGGCAGCAGCTTGGGCTTC b562(-21) 
SC-b562-G70A_F GCGGAGATTGATGATGCTTTGAAGCTGGCGAACGAAGG b562(-21) 
SC-b562-G70A_R CACCAGAATGTCGAAGCCATGCTCCC b562(-21) 
SC-b562-S59K_F AAGGATTGGGAGCATGGCTTCGACATTCTG b562(-19) 




3.3 Salt Dependence of the Folding 
At 20 mM borate, pH 9.0, apo-b562(-27) has a CD spectrum indicative of predominantly 
random coil structure at salt concentrations in the range 0 – 4 M NaCl. Due to the high net 
charge of our initial design, the electrostatic repulsive force between the glutamates overwhelms 
the core packing energy. In order to reduce this high electrostatic energy, the pH can be lowered 
such that a small population of the glutamic acid residues will be protonated at all times, thereby 
lowering the net charge of the protein. Consequently, b562(-27) alpha-helix character is not 
detectable by CD spectroscopy until the pH is lowered to 5.5 and the NaCl concentration is at 
least 2 M (Figure 20). The protein becomes predominantly helical at concentrations over 3 M 
NaCl. 
 
Figure 20: A. Ellipticity spectra of apo-b562(-27) as measured by circular dichroism spectroscopy at 20 mM MES, pH 5.5 and 
increasing NaCl concentrations. B. The ellipticity value at 222 nm, corresponding to the absorption band indicative of alpha-
helical structure plotted as a function of NaCl concentration. Protein was prepared at a concentration of 2.5 µM in 20 mM MES, 
pH 5.5and varying NaCl concentrations. 
 
The salt titration demonstrates that the folding energy of apo-b562(-27) depends linearly 
on salt concentration (Figure 21). At ionic strength less than approximately 2250 mM NaCl, the 
electrostatic repulsion of the negatively charged glutamate residues cannot be overcome by the 
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core packing-driven hydrophobic effect, thus driving the ensemble to be in an extended state. At 
ionic strength greater than 2250 mM NaCl, the electrostatic fields of the charged residues begin 
to be screened by the ions in solution. This screening effect reduces the electrostatic energy of 
the structure, allowing the hydrophobic effect to be the overwhelming force which drives b562(-
27) to fold and exhibit a predominantly helical structure. 
 
Figure 21: Stability of apo-b562(-27) at 20 mM MES, pH 5.5 as a function of NaCl concentration as measured by salt titration 
and urea melt. The red line is a linear fit. 
 
 3.4 Ligand-Induced Folding 
The tetrahelical bundle, b562(-27), non-covalently binds one equivalent of IHP ligated to 
the residues M7 and H102 
80
. At 20 mM MES, pH 5.5 and NaCl concentrations higher than 1 M, 
IHP forms aggregates within minutes, hence reliable binding titrations cannot be performed in 
order to determine the ligand binding constant. However, this aggregation does not preclude 
monomeric IHP in solution from binding to the protein. Therefore, it is confirmed that b562(-27) 
retains its ability to bind IHP when it is mostly folded, i.e. at high salt (Figure 22), via UV-Vis 
spectroscopy an observing the 406 nm Soret band of bound oxidized IHP. Furthermore, ligand-
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induced partial folding has been confirmed. At 20 mM mES, 2 M NaCl, pH 5.5, titrated with 
IHP, b562(-27) only exhibits an increase in its alpha-helical character from 31% to 57% (Figure 
23), never reaching the full helical content observed with the NaCl titration alone (Figure 21) 
even with as much as 1500 equivalents of IHP. Although, due to IHP aggregation at low pH and 
high salt, no definitive binding constants can be collected, this data demonstrates that the 
supercharged version of E. coli cytochrome b562 exhibits IDP behavior.  
 
 
Figure 22: Absorption spectra of b562(-27) titrated with concentrated IHP in 20 mM MES, 3000 mM NaCl, pH 5.5. B. Replot of 




Figure 23: CD absorption spectrum of b562(-27) titrated with IHP at 20 mM MES, 2 M NaCl, pH 5.5. 
 
It has become clear that, while I have succeeded in disrupting the stability of b562(WT), 
the magnitude of the disruption has made the supercharged protein prohibitively unstable, 
disallowing experiments to be performed under solution conditions that are tolerable for oxidized 
IHP binding. To reduce the electrostatic effects of the surface charged residues, the simplest 
approach is to select surface-exposed acidic or neutral amino acids and mutate them to neutral or 
basic amino acids, respectively. 
 
 3.5 Redesign of Supercharged Cytochrome b562 
 The net charge of the b562(-27) was iteratively reduced by targeting areas where 
negatively charged residues were more highly clustered and mutating one or two of the amino 
acids back to the amino acid found at that location in b562(WT). The result of this iterative 
procedure yielded four more supercharged b562 proteins: b562(-25), b562(-21), b562(-19), and 
b562(-18), with net charge per residue of -0.24, -0.20, -0.18, and -0.17, respectively (Table 3). 
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The first two attempts at lowering the net charge, b562(-25) and b562(-21), did not have 
improved stability over b562(-27) (Figure 24). The two lowest charged variants, b562(-19) and 
b562(-18), showed an improved stability of 1.6 and 2.1 kcal/mol, as determined by the intercept 
of folding energy at 0 M NaCl (Figure 24). Consequently, b562(-18) can be folded at pH 7.0 
(Figure 25), for which IHP and heme do not aggregate as quickly as when at pH 5.5. 
 
 
Figure 24: Stability of supercharged variants of apo-b562 at 20 mM MES, pH 5.5 as a function of NaCl concentration as 
measured by salt titration. The data was fit with a linear best fit line. 
 
Figure 25: A. CD absorption spectra of apo-b562(-18) at 20 mM MOPS, pH 7.0 and NaCl concentrations ranging from 0 to 4 M. 




3.6 Ligand-Induced Folding and Kinetics of Redesigned Supercharged b562 
 Thermodynamic measurements with IHP were unsuccessful because the binding constant 
was too weak to measure due to its partial hydrophilic character. Instead oxidized ferric heme 
was used, which was found to bind well to b562(-18) over the target NaCl concentrations.  
 At 20 mM MOPS, 2 M NaCl, pH 7.0 apo-b562(-18) is predominantly unfolded as 
determined by circular dichroism spectroscopy (Figure 26). The protein can be induced to fold 
upon the addition of heme, whereby the energy of the bound cofactor within the folded structure 
is lower than the extended coil (Figure 26). However, the holoprotein at 2 M NaCl was found to 
be only 58% folded when the CD spectrum was compared to that of apoprotein at high ionic 
strength, a behavior similar to its progenitor, b562(-27). The data indicates that the protein only 
needs to be partially folded to form a stable bond between the heme and its binding site; portions 
of the protein distant from the binding site may not be induced to fold and remain extended at 





Figure 26: Apo- and holo-b562(-18) CD spectra of b562(-18) at 20 mM MOPS, 2 M NaCl, pH 7.0. 
 
 At all concentrations of NaCl tested, heme binds on the time scale of minutes (Figure 
27A). Due to this slow, stochastic process, there is competition between the binding and heme 
aggregation; therefore, once binding stops, the Soret band begins to decay. Interestingly, as the 
NaCl concentration increases, the effective rate constant decreases (Figure 27B). The non-
supercharged version, b562(WT), shows a similar effect, indicating that the reduction of the on 
rate with increasing NaCl concentration is not a result of supercharging (Figure 27). It is 
important to note that for b562(-18), the fraction of the protein that is bound increases with 
higher salt, whereas for b562(WT) the fraction bound remains the same for all salt 
concentrations, as evidenced by the final magnitude of the Soret band absorbance once the 




Figure 27: A. The Soret band absorbance (𝑨𝟒𝟏𝟔) of heme binding with b562(-18) as a function of time over a range of time at 
NaCl concentration ranges from 1.0 M to 4.0 M. Data was fit with Equation 9, and the fitted data was truncated prior to the decay 
of the Soret band due to heme aggregation. B. The effective rate constant as a function of NaCl concentration for both b562(WT) 
and b562(-18) 
 
 Due to the slow binding of heme with b562(-18) and its competition with aggregation, it 
is not possible to determine the binding energy under these conditions. Another iteration of 
mutations, in which the net charge of b562(-18) is lowered, thereby stabilizing the protein further 




Chapter 4: Divalent Cations and Cooperativity 
 
4.1 Background 
Metal cations are crucial for many biological pathways and functions. Metalloproteins 
and metal-sensitive proteins have been receiving increased interest as their role in protein 
stability and catalysis becomes better understood 
81–84
. For protein folding, divalent cations have 
been shown to act as stabilizing crosslinkers between acidic residues 
85–89
. Specifically, calcium 
ions have been shown to be allosteric effectors that are tightly controlled in eukaryotic cells, as 
seen by calmodulin proteins 
90–93
. Furthermore, aberrant concentrations of metal cations in vivo 
have been implicated as possible causes for some neurological diseases due to protein 
aggregation or unusually fast folding 
58–61
. Similarly, polyamines, such as spermine, play 
important roles in translation initiation, cell growth, and protein and nucleic acid synthesis 
98–101
, 
yet they have also been identified as a cause for protein misfolding and aggregation 
102–105
.  
Due to their universal influence on stability, folding rates, and most recently discovered 
binding rates 
106
, many have sought to design proteins that are sensitive to multivalent cations 
107–113
. Calcium ion binding sites modeled after EF-hands have been introduced into natural 
proteins to stabilize the native fold 
114–116






In addition to multivalent metal sensitivity, allostery has been of high interest to synthetic 
biologists as a method for modulating control networks. Allostery is typical in many systems and 
present in a large portion of IDPs. The ability to impart and modulate allosteric behavior gives an 




4.2 Materials and Methods 
 4.2.1 Protein Preparation. N4(-28) was expressed and purified as previously described 
in section 2.3.1. 
4.2.2 Salt Refolding. CD spectra were recorded on an Aviv Biomedical Circular 
Dichroism Spectrometer Model 400 in a quartz cell with a 0.2 cm light path, using a bandwidth 
of 1 – 2 nm, an averaging time of 2 s, and averaged over two scans. 
 For salt refolding experiments, concentrated apoprotein stocks were prepared at 30 μM in 
20 mM MOPS, 15 mM NaCl, pH 7.0.  The protein stocks were diluted to 2.5 μM for experiment 
samples. Concentrated stocks of titrants were prepared at 20 mM MOPS, 15 mM NaCl, pH 7.0 
with the following titrant concentrations: 500 mM CaCl2, 750 mM MgCl2, 10 mM ZnCl2, 10 mM 
spermine hydrochloride, and 2 mM TbCl3. Titrants were added at 1 µL additions, mixed by 
inversion, and allowed to equilibrate for 1 min – no significant change in the CD spectra was 
observed for longer equilibration times. Spectra were recorded between 204 nm and 250 nm, 
with background correction. Analysis and folding energy determination are described in section 
2.3.2. 
 4.2.3 Chemical Denaturation. Apo-N4(-28) stocks were prepared at 30 μM in 20 mM 
MOPS, pH 7.0 and at four CaCl2 concentrations (24.45, 52.25, 96.15, 186.15 mM). The stocks 
were diluted to 2.5 μM in a range of urea concentrations from 0 to 8 M. CD spectra showed no 
significant change when the samples were equilibrated for 24 h, therefore equilibration time was 
not strictly monitored and was normally on the order of minutes. Spectra were recorded between 
210 nm and 250 nm, with background correction. Analysis and folding energy determination are 
described in section 2.3.3. 
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4.2.4 Cofactor Binding.  UV-Vis Spectroscopy — Optical spectra were recorded with a 
Hewlett-Packard 8452A diode array spectrophotometer. Apoprotein samples were 0.5 μM in 20 
mM MOPS, 50 mM NaCl, pH 7.0 with varying divalent cation concentrations specifically noted 
throughout. Experiments were performed in 1 cm path length glass cuvettes. The cofactor, 
Fe(III) Isohematoporphyrin IX (IHP) (Frontier Scientific), was suspended in DMSO at 
concentrations between 1 mg/mL and 5 mg/mL. Successive 0.3 – 5 equivalent additions of IHP 
were followed by at least a 1.5 min equilibration period. Optical spectra were collected after each 
equilibration period and the cofactor binding was monitored using the bound IHP Soret peak at 
404 nm. Data was normalized to reflect the fraction of protein bound to the cofactor. Values for 
Kd were obtained from plots of the Soret band absorbance measured at 404 nm vs. the 
concentration of IHP added and fit with least squares regression analysis using Equation 6. 
 4.2.5 Stopped-Flow Analysis of IHP Binding. The kinetics of binding IHP to N4(-28) 
were followed spectroscopically in rapid stopped-flow mixing experiments over CaCl2 
concentrations from 2 to 80 mM at 25° C using a Biologic SFM 300 stopped-flow mixer 
equipped with a custom-built Olis RSM 1000 spectrometer for multiwavelength detection. 20 
mM MOPS, 15 mM NaCl, 20 or 80 mM CaCl2 was mixed with buffer not containing CaCl2 in 
the first mix, and then this mixture was combined in a second mix with N4(-28), and finally the 
resulting mixture was mixed with IHP. Final protein concentrations were 0.5 µM with 2.5 µM 
IHP. Holoprotein was followed spectroscopically by following the bound oxidized IHP Soret 
band at 404 nm, 𝐴404. Binding kinetic data were fit with the equation 
 𝐴404 = (𝐴f − 𝐴0)𝑒
−𝑡∙𝑘on
obs
+ 𝐴0. (10) 
Here, 𝐴f is the final absorbance at 404 nm, 𝐴0 is the initial absorbance at 404 nm, 𝑡 is time in 
seconds, and 𝑘on
obs is the effective binding rate constant. 
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4.3 Multivalent Cation Dependence of Folding Energy 
Due to the low solubility of many multivalent ions at high pH, the folding energy 
dependence of N4(-28) on these ions was determined at pH 7.0. In 20 mM MOPS, 15 mM NaCl, 
pH 7.0 buffer apo-N4(-28) has a CD spectrum indicative of a predominantly random coil 
structure, yet the development of alpha-helices is extremely sensitive to divalent metals and 
spermine hydrochloride (Figure 28). The 95% folded threshold for MgCl2 is just 21 mM, while 
for the most sensitive response divalent ions is for ZnCl2 with a 95% folded threshold at 180 µM. 




Figure 28: Circular dichrosim spectra of N4(-28) at 20 mM MOPS, 15 mM NaCl, pH 7.0 titrated with A. MgCl2, B. CaCl2, C. 




Figure 29A shows the folding energy as a function of cation concentration as determined 
from the CD titrations. For all divalent titrants, the folding energy is linearly dependent on the 
concentration just as with NaCl with a much higher sensitivity. This indicates that divalent 
cations produce stronger screening effects between neighboring glutamate residues than the 
monovalent salt NaCl. According to Debye-Hückel theory 
120
, the amount of screening can be 
quantified as a function of the solution ionic strength: 





where 𝜆𝐷 is the Debye length which describes the distance that the electrostatic effect of a charge  
persists in an electrolyte solution of ionic strength 𝐼. Further, 𝜖0 is the permittivity of free space, 
𝜖𝑟 is the dielectric constant of the solvent, 𝑘𝐵 is Boltzmann’s constant, 𝑇 is the temperature in 
Kelvin, 𝑁𝐴 is the Avogadro number, and 𝑒 is the unit charge. For water at room temperature, this 





Figure 29B shows the folding energy of N4(-28) as a function of Debye length for all cations. 
This demonstrates that the higher valancy cations lower the folding energy of the protein at 
lower concentrations due to their higher ionic strength, 𝐼, and consequently stronger screening. 
Furthermore, it is clear that though a higher valency number of the ions in solution is better for 
stabilizing the protein, the valency number alone does not determine the magnitude of this 










Figure 29: The folding energy of N4(-28) at 20 mM MOPS, 15 mM NaCl, pH 7.0 as a function (A) divalent titrant 
concentration (B) Debye length. 
 
With the clear dependency of N4(-28) folding energy on the valency of the cation in 
solution, the trivalent metal, Tb
+3
, was used as a titrant to determine if a higher valency would 
stabilize the protein even further (Figure 30). Similar to previously described salt titrations, N4(-
28) becomes more alpha-helical as the TbCl3 is added up to a concentration of approximately 30 
mM. Interestingly, past 30 mM N4(-28) begins to lose its alpha-helical character and denature. 
This is contrary to what is observed with mono- and divalent salts where the addition of more 




Figure 30: A. Circular dichroism spectra of apo-N4(-28) as measured by circular dichroism spectroscopy at increasing NaCl 
concentrations. B. The ellipticity value at 222 nm plotted as a function of NaCl concentration. Protein was prepared at a 
concentration of 2.5 µM in 20 mM MOPS, pH 7.0 and varying NaCl concentrations. 
 
In section 2.4 it was found that the stability of N4(-28) continues to increase at a constant 
rate well past the NaCl concentration at which the protein contains all of its alpha-helical 
character. To determine if N4(-28) shows the same behavior with divalent cations, urea 
denaturation experiments were conducted at higher CaCl2 concentrations (Figure 31). The 




Figure 31: Urea melts of N4(-28) at pH 7.0, 20 mM MOPS with varying CaCl2. The fits were calculated using the non-linear 
method of least squares to Equation 5. 
 
[CaCl2] (mM) 𝛥𝐺fold (kcal/mol) 
24.45 -2.74 ± 0.09 
52.25 -3.0 ± 0.2 
96.15 -3.5 ± 0.3 
186.15 -4.6 ± 0.6 
 
Table 5: The folding energy of N4(-28) at CaCl2 concentrations ranging from 24.45 to 186.15 mM as determined by urea melt 
and least squares fit to Equation 5. Errors are determined using the inverse matrix method. 
 
Together, the salt titration and urea melt data demonstrate that, like NaCl, CaCl2 
continues to stabilize N4(-28) beyond the point at which it has already completely folded (Figure 
32). However, unlike NaCl, there are two distinct regions where the folding energy depends 
linearly on the CaCl2 concentration, but with different slopes. Below 10 mM CaCl2, the slope is -
0.34 kcal/mol per mM CaCl2, whereas above 10 mM the slope is reduced to -0.01 kcal/mol per 
mM CaCl2. This indicates that there are significantly different processes happening in these two 
CaCl2 ranges. Notably, when plotted as a function of ionic strength (Figure 33), above an ionic 
strength of 0.045 M, the slopes of the folding energy obtained with both CaCl2 and NaCl are the 
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same within experimental error. This indicates that with CaCl2, the process happening at higher 
ionic strengths is identical to that of NaCl, namely electrostatic screening. At low ionic strengths, 
the steeper slope of the folding energy with CaCl2 is suggestive of binding events occurring. 
 
 
Figure 32: Stability of apo-N4(-28) as a function of CaCl2 concentration as measured by salt titration and urea melt. The best fit 
line for each method is drawn. 
 
 
Figure 33: Stability of apo-N4(-28) as a function of ionic strength for both NaCl and CaCl2. 
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4.4 Cooperative Ligand Binding Triggered by Multivalent Cations 
The high density of negative residues on the surface of N4(-28) is favorable for lowering 
the folding energy substantially by binding to divalent cations. At 20 mM MOPS, 50 mM NaCl, 
pH 7.0, the protein is predominantly unfolded (Figure 34). Adding a small amount of divalent 
cation folds N4(-28) only slightly further, yet the protein remains significantly more unfolded 
than folded. At 50 mM NaCl, two equivalents of IHP bind weakly with a dissociation constant of 
8 ± 1 µM. The addition of 1 mM CaCl2 reduces the dissociation constant to 0.22 ± 0.02 µM, 
making the IHP binding significantly tighter. The binding curves for N4(-28) at 50 mM NaCl 
and the additional divalent cation are shown in Figure 35. The binding constants, and apparent 
binding energies for all divalent cations are shown in Table 6. The large drop in binding energy 
for all multivalent cations tested indicates that it is likely Mg
2+
 and spermine also bind to the 
negatively charged surface residues of N4(-28) and drive the dissociation constant down. ZnCl2 
does not appear in Table 6 because it precludes the IHP from binding. Zinc is known to form 
complexes with bis-His binding sites 
121,122
, the same that are found in N4(-28), thus the IHP is 









Figure 35: Binding curves of N4(-28) with IHP. Replot of the IHP Soret band at 404 nm throughout the titration. Data is fit to 







Ion concentrations 𝐾𝑑 (µM) 𝛥𝐺bind
app
 (kcal/mol) 
50 mM NaCl 8 ± 1 -7.04 ± 0.08 
50 mM NaCl, 1.5 mM MgCl2 0.52 ± 0.03 -8.68 ± 0.03 
50 mM NaCl, 1 mM CaCl2 0.22 ± 0.02 -9.20 ± 0.05 
50 mM NaCl, 60 µM spermine 0.27 ± 0.03 -9.1 ± 0.1 
 
Table 6: The dissociation constant, 𝑲𝒅, and apparent binding energy, 𝜟𝑮𝐛𝐢𝐧𝐝
𝐚𝐩𝐩
, of N4(-28) with IHP in the presence of 
cooperativity inducing divalent cations. Dissociation constants are determined using least squares fits of binding curves to 
Equation 6 and errors are determined using the inverse matrix method. 
 
The process by which N4(-28) binds to divalent cations in order to increase its affinity for 
a ligand, namely IHP, renders the cations allosteric modulators. This provides another handle for 
tuning the folding and binding energy of a supercharged protein. Designing allostery has large 
implications in synthetic biology and biosensing for developing molecular switches sensitive to 
small fluctuations in ion concentration. 
 
4.5 Rates of IHP Binding 
The observed IHP on rates for increasing CaCl2 concentrations are shown in Figure 36A. 
At 2 mM CaCl2 the observed on rate is 0.23 ± 0.01 s
-1
. The fastest rate observed is at 40 mM 
CaCl2 with 1.82 ± 0.03 s
-1
. Although data is shown to CaCl2 concentrations out to 80 mM, the 
observed on rates of IHP are effectively constant beyond 40 mM CaCl2 within experimental 
error. The data demonstrates that the observed on rate, 𝑘on
obs, increases with calcium 
concentration, indicating that as more of the protein ensemble folds, the available fully formed 
binding sites increases allowing for the IHP to bind more readily. Notably, this is the opposite 
trend than that of the supercharged extant protein, b562(-18) showed (Figure 27). It follows that 
the fraction of N4(-28) that is folded determines the observed IHP on rate. Consequently, the 
ratio of the effective on rate to the concentration of molten globule protein, i.e. folded 
 
 56 
apoprotein, is independent of the CaCl2 concentration (Figure 36B), yielding an IHP on rate with 
N4(-28) of 1.02 ± 0.02. 
 
 
Figure 36: A. The effective binding constants of IHP with N4(-28) at 20 mM MOPS, 15 mM NaCl, pH 7.0, in the range of CaCl2 
concentrations from 2 mM to 80 mM. B. The on rate of IHP to N4(-28). Data collected and analyzed by Dr. Mia Brown, to whom 
I am eternally grateful for learning to use a stopped-flow on my behalf. 
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5. Future Directons: Biosensing 
 
5.1 Applications of Imparting IDP Behavior 
The applications of the engineering principles developed to impart IDP behavior to both 
designed and natural proteins are far reaching. For example, kinase proteins, which have been 
identified as principal players in cancer and other diseases 
123
, have the key function of 
transferring phosphate groups, i.e. negative charge, to other proteins. I am developing a 
positively supercharged green fluorescent protein whose chromophore will not mature until the 
net charge is reduced by the addition of negative charge by kinases allowing it to fold. 
Monitoring kinase activity in vivo could shed light on the roles they play in certain diseases. 
Another example of the applications of imparting IDP behavior to natural proteins is 
controlling the expression of an indicator protein by making a cation sensitive lac repressor. 
Many vector plasmids use the lac operon as a means of controlling the expression of a gene 
downstream of it; the lac repressor binds to the DNA at the lac operon preventing gene 
expression until lactose or some other binding partner of the repressor is present. By 
supercharging the lac repressor so that it is sensitive to small concentrations of divalent cations, I 
can monitor the flux of these cations in vivo by the unfolding or folding of the lac repressor and 
its subsequent binding to the operon, thereby turning on and off the gene it controls. This can 
prove important for identifying and understanding the pathways that are disrupted or activated by 
small ion fluxes, such as Ca
2+
 or Zn 
2+
 which have been shown to play a part in cell development 
124
, neurological signaling 
125
, phosphatase activity 
126
, and apoptosis 
124,127
. 
One last example, for which I have developed extensively, lies in using IDPs as 
biosensors. The most widely used of the available biosensing techniques relies on 
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immunoassays, which often achieve detection sensitivity as low as the ppb range. These assays 
use antibodies that bind to the target and produce a signal via a labeling agent, often enzymatic, 
radioactive, or fluorescent. In place of label-based techniques, surface plasmon resonance (SPR) 




5.2 Supercharged Protein Potential as a Biosensor Using Localized SPR 
Localized SPR is a more sensitive version of SPR which uses conductive nanoparticles as 
the source of plasmons rather than bulk material. Briefly, when visible light is incident on these 
nanoparticles, the incoming electromagnetic field excites plasmons at the surface of the 
conductive material. When the wavelength of light matches the plasmon resonance frequency, 
the light is absorbed. The resonance frequency is dependent on nanoparticle composition, but 
more importantly on the refractive index of the medium near the surface of the nanoparticle 
129,130
. Since proteins, such as antibodies, have refractive indexes they can be attached to the 
nanoparticles and used to detect their binding partners. When the binding event occurs, the 
additional polarizable mass causes a change in the refractive index at the surface of the 
nanoparticle and can be sensed by a shift of the peak wavelength of the absorption spectrum. To 
date, structurally rigid proteins have been used in SPR, and upon ligand binding there is a 
detectable change in refractive index in the range of 0.0001 – 0.001. By using supercharged IDPs 
that would undergo a large-scale structural transition upon binding, I could increase the 
refractive index change, creating a much more sensitive method for bioassays. 
5.2.1 Predicting LSPR Signal. The presence of supercharged IDPs on a gold 
nanoparticle will induce a refractive index at the gold/sample interface. After binding to the 
target ligand, the protein will undergo a large conformational change that will affect the 
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refractive index of the sample just above the gold surface. To determine the magnitude of this 
change I will need to estimate the refractive index of our protein using a method outlined by 
McMeekin et al. 
131,132
. The refraction per gram of protein, 𝑅𝑝, is calculated as the mass weighted 





where 𝑀𝑎 is the molecular mass of residue 𝑎. Additionally, the partial specific volume of the 






Finally, by applying the Lorentz-Lorenz formula, an estimate of the refractive index of the 
protein is 




Using the molar refraction of each amino acid reported by McMeekin 
131
, and the corresponding 
partial specific volume reported by Cohn 
133
, the typical refractive index for our IDP is 𝑛𝑝𝑟𝑜𝑡 =
1.514. 
Due to the electrostatic repulsive forces discussed earlier, the protein can be assumed to 
have a rigid rod conformation when attached to the gold (Figure 37A). We estimate the volume 
of the extended protein as a rectangular box with a square footprint of side length 0.75 nm and a 
height of 472.5 nm, i.e. 0.35 nm per amino acid. For simplicity, we will assume each structure 
sits on a grid, each occupying one corner of a 2.5 × 2.5 nm square (Figure 37B). The interstitial 
space will be filled with water. A simple estimate of the total effective refractive index above the 
gold, 𝑛𝑒𝑓𝑓,1, has been established by Jung et al. 
134
. The SPR signal is the result of the interaction 
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of the evanescent field with the refractive index of the sample. For gold nanoparticles of 100 nm 
diameter, the penetration depth of this field is 𝛿 ≈ 40 nm 135 and the intensity decays as 𝑒−2𝑦/𝛿. 
As such, the effective refractive index is determined by weighting the local refractive index by 
the intensity along the perpendicular distance from the gold surface. For our example, the first 
472.5 nm have the volume weighted refractive index of the water and protein, and farther out 




{∫ (0.0625𝑛𝑝𝑟𝑜𝑡 + 0.9375𝑛𝑤)𝑒
−2𝑦/𝛿472.5
0
𝑑𝑦 + ∫ 𝑛𝑤𝑒
−2𝑦/𝛿∞
472.5
} = 1.3415. (16) 
Here, 𝑛𝑤 = 1.33, the refractive index of water. 
Once the target analyte is introduced the protein will fold into a rigid structure at the 
surface of the gold, occupying the entire area of the 2.25 × 2.25 nm square with a height of 











𝑒−2𝑦/𝛿𝑑𝑦} = 1.3707 . (17) 
The predicted shift in the wavelength, 𝛥𝜆, can be determined using the equation  
 𝛥𝜆 = 𝑚(𝑛𝑒𝑓𝑓,2 − 𝑛𝑒𝑓𝑓,1) . (18) 
Here, 𝑚 is the refractive index sensitivity (RIS) in nm/RIU (refractive index unit). The RIS was 
experimentally determined to be 130.16 nm/RIS, making the expected shift in resonance 
wavelength 3.80 nm. This substantial increase in the effective refractive index upon ligand 
binding will result in a resonance wavelength shift almost 30 times the typical SPR signal 




Figure 37: A. Extended supercharged protein conformation attached to gold. B. Top view of protein array where shaded areas 
indicate surface area occupied by a single extended protein. Large boxes represent the surface area occupied by a folded protein. 
C. Folded protein upon binding to ligand. 
 
This calculation did not account for the charged residues on the IDP and should be 
considered a lower limit to the effect of the conformational change on the refractive index. The 
carboxylate groups of the charged protein will contribute significantly to the polarizability of the 
structure, increasing the effective refractive index above the gold nanoparticles. Also, the RIS 
can be tuned and optimized by adjusting the diameter and thickness of the gold nanoparticles 
135
. 
Additionally, strong image charges will be induced on the gold film and may act as a strong 
perturbance to the resonance frequency of surface plasmons. 
 
5.3 Materials and Methods 
 5.3.1 Protein Modification for Au Linkage and Preparation. Genes for the diheme 
binding tetrahelical bundles, N4-Cys and N4(-28)-Cys, were were synthesized (GeneWiz) and 
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subcloned into the vector plasmid pET32a (Novagen). N4-Cys and N4(-28)-Cys are identical to 
their progenitors, N4 and N4(-28), but with a C-terminal cysteine tag consisting of three glycine 
residues followed by a cysteine (Table 7). The reactive thiol group at the C-terminus assists in 
linking the proteins to the gold. The proteins were expressed and purified as previously described 
in section 2.3.1. 
 
Protein Sequence 
N4-Cys GEIWKQHEEALKKFEEALKQFEELKKL GGSNSGSGG     
 EIWKQHEEALKKFEEALKQFEELKKL GGSSTGSGG  
 EIWKQHEEALKKFEEALKQFEELKKL GGSSGGSGG  
 EIWKQHEEALKKFEEALKQFEELKKL GGGC 
N4(-28)-Cys GEIWQQHEEALQQFEEALQQFEELQQL GGSNSGSG  
 EIWQQHEEALQQFEEALQQFEELQQL GGGGSSTGSG  
 EIWQQHEEALQQFEEALQQFEELQQL GGSSGGSG  
 EIWQQHEEALQQFEEALQQFEELQQL GGGC 
 
Table 7: Amino acid sequences for N4-Cys and N4(-28)-Cys, with a C-terminal cysteine for attachment to gold nanoparticles. 
 
5.3.2 Functionalizing Gold Nanoparticles. Self-Assembled Monolayer — Bare gold 
nanoparticles attached to glass chips were supplied by Nicoya Lifesciences. The chips were first 
cleaned by submersion in piranha solution, followed by thorough washing with water, then 
ethanol and dried with N2. Next, the chips were immersed overnight in a 100 mM 3-mercato-1-
propanol, 1 mM 1-mercaptopropionic acid ethanolic solution to form a self-assembled 
monolayer (SAM). Afterwards, the chips were washed with ethanol, dried with N2, and placed in 
the SPR spectrometer (Nicoya Lifesciences). Prior to surface attachment, the lyophilized protein 
was resuspended in Protein Coupling Buffer (20 mM HEPES, pH 7.0, 750 mM NaCl), degassed, 
reduced with 10x molar excess of TCEP (Tris(2-carboxyethyl)phosphine hydrochloride), and 
allowed to sit at room temperature under nitrogen for approximately 30 min.  
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Linking Protein to SAM via a Bifunctional Crosslinker — The gold nanoparticle covered 
surface with the SAM was equilibrated with 10 mM MES pH 5.5. To begin, the surface was 
exposed to 200 mM EDC (N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride) and 
2 mM MPA (3-maleimido-propionic acid) for 8 min, during which an intermediate was formed 
by the two free molecules which then covalently bound to the SAM at the amine group (reaction 
1 and 2 in Figure 38). This step was followed by quickly washing with degassed Protein 
Coupling Buffer (20 mM HEPES pH 7.0, 750 mM NaCl ). Next, the reduced and degassed 
protein was allowed to flow over the chip for 20 min (reaction 3 in Figure 38), followed by a 
wash with Protein Coupling Buffer. Finally, the unreacted maleimide terminated molecules were 
blocked and inactivated by flowing 1 M 2-mercaptoethanol over the fully functionalized chip for 
7 min, followed by washing with 50 mM HCl to recharge. 
 
Figure 38: Reaction scheme for attachment of protein to amine-terminated SAM on Au nanoparticles. 
 
 
5.3.3 SPR Spectroscopy. The functionalized chip was equilibrated with Experiment 
Buffer (20 mM HEPES, 15 mM NaCl, pH 7.0) at a flow rate of 50 µL/min. Then 80 µL of 2 mM 
ZnCl2 in Experiment Buffer, was injected into the SPR line and flowed over the chip and the 
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change in SPR signal was observed. Finally, the chip would be washed with Experiment Buffer 
to recharge the surface. 
 
5.4 SPR Response to Protein Folding 
In early studies I found that heme and IHP tended to lodge itself in the monolayer due to 
its hydrophobic character, causing an irreversible shift in the SPR signal, and was therefore not a 
reliable indicator of whether a conformational change had occurred. From section 4.3, divalent 
salts are capable of driving the conformational change at concentrations up to three orders of 
magnitude lower than monovalent salts. N4(-28)-Cys undergoes a conformational change with 
the addition of 2 mM ZnCl2, while an equivalent amount of ZnCl2 has no effect on the 
conformation of the neutral N4-Cys. Therefore, 2 mM ZnCl2 was used instead of heme or IHP to 
induce a conformational change in gold-bound N4(-28)-Cys. 
The SPR responses of chip functionalization and protein folding for both N4-Cys and 
N4(-28)-Cys are shown in Figure 39. Since the refractive indices of N4-Cys and N4(-28)-Cys 
should be approximately identical according to the calculations in section 5.1, the SPR response 
to the fully folded structures should be the same. Because the protein coupling reaction is 
performed at high ionic strength, both structures are folded during this step, and so a larger 
change in the SPR signal indicates a high concentration of surface-attached protein. As such, it is 
obvious that the 1.09 nm shift in the SPR signal when attaching N4-Cys indicates it attached 




Figure 39: Time course display of the SPR response for both A. N4 and B. N4(-28) during functionalization and the ZnCl2 
sensing experiment. 
 
To determine the protein folding response, 2 mM ZnCl2, 20 mM HEPES pH 7, 15 mM 
NaCl was injected to flow over the functionalized chip. N4-Cys and N4(-28)-Cys showed a 0.12 
nm and 0.22 nm increase in the SPR response, respectively. Correcting for the relative protein 
concentrations, we conclude that the SPR shift per protein molecule for N4-Cys is 0.11 nm and 
for N4(-28)-Cys is 0.43 nm. Hence with this method, we have shown the conformational change 
of N4(-28)-Cys yields a response that is 3.75-fold greater with than with N4-Cys. This signal 
enhancement is modest when compared to the theoretical calculations above, but I believe that 
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